COVID-19 vaccination in Europe - Cornelli, Umberto;Belcaro, Giovanni;Recchia, Martino
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

The death rates after the start of the vaccination program are very different in the 47 countries representing Europe, although a very similar number of vaccine shots have been administered in the countries most affected by the pandemic. One exception to this is the UK, where the number of vaccinations is about three times higher. As in the rest of the world, a temporary decrease in the number of deaths in Europe was followed by an increase. However, the trends are different in each country, and a clear decrease is currently only taking place in ten European countries. Why do these differences…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The death rates after the start of the vaccination program are very different in the 47 countries representing Europe, although a very similar number of vaccine shots have been administered in the countries most affected by the pandemic. One exception to this is the UK, where the number of vaccinations is about three times higher. As in the rest of the world, a temporary decrease in the number of deaths in Europe was followed by an increase. However, the trends are different in each country, and a clear decrease is currently only taking place in ten European countries. Why do these differences exist? Why is there an increase in the number of deaths?The first cause is mistakes in the organization of the vaccine campaign in some countries. Often people had to wait in long queues outside vaccination centres in large cities, sometimes in cold weather. Everyone is waiting for herd immunity, but before that happens, if it ever happens, many more deaths will occur. Our real hope is a drift towards a non-lethal variant. In conclusion, COVID-19 has shown that the European Health System has to be completely reorganized in a proper manner.
Autorenporträt
Prof Cornelli is an Adjunct Professor at Loyola University School of Medicine since 1995. He is a clinical pharmacologist and studied many drugs. He wrote 200 papers for International Journals, five books, and holds 15 international patents. In 2002 he received the honorary degree in Science from the Loyola University School of Medicine-Chicago.